A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2024
The main objective of the study is to characterize safety and efficacy of 2 dose levels of AMG 193 by investigator, and to evaluate AMG 193 monotherapy efficacy by Blinded Independent Central Review (BICR).
Epistemonikos ID: d31a130b4d26c6243956115b278f207fbfedd82e
First added on: Oct 01, 2024